Advertisement
Screener

EMERGENT BIOSOLUTIONS INC. (EBS) Material Contracts, 2012

EMERGENT BIOSOLUTIONS INC. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2012-11-01: Form 10-Q; Exhibit 10.3; Description Modification No. 2 to Contract No. 200-2011-42084, effective September 1, 2012, between Emergent BioDefense Operations Lansing LLC and the Centers for Disease Control and Prevention..
  • 2012-11-01: Form 10-Q; Exhibit 10.2; Description Modification No. 1 to Contract No. 200-2011-42084, effective March 21, 2012, between Emergent BioDefense Operations Lansing LLC and the Centers for Disease Control and Prevention..
  • 2012-11-01: Form 10-Q; Exhibit 10.1; Description Second Amendment to Loan Documents, dated as of August 3, 2012, among the Company, Emergent Manufacturing Operations Baltimore LLC, Emergent BioDefense Operations Lansing LLC and PNC Bank, National Association..
  • 2012-08-03: Form 10-Q; Exhibit 10.8; Description Amendment to Loan Documents, dated as of July 11, 2012, among the Company, Emergent Manufacturing Operations Baltimore LLC, Emergent BioDefense Operations Lansing LLC and PNC Equipment Finance, LLC..
FiledFormExhibitDescription
2012-11-0110-Q10.3Modification No. 2 to Contract No. 200-2011-42084, effective September 1, 2012, between Emergent BioDefense Operations Lansing LLC and the Centers for Disease Control and Prevention.
2012-11-0110-Q10.2Modification No. 1 to Contract No. 200-2011-42084, effective March 21, 2012, between Emergent BioDefense Operations Lansing LLC and the Centers for Disease Control and Prevention.
2012-11-0110-Q10.1Second Amendment to Loan Documents, dated as of August 3, 2012, among the Company, Emergent Manufacturing Operations Baltimore LLC, Emergent BioDefense Operations Lansing LLC and PNC Bank, National Association.
2012-08-0310-Q10.8Amendment to Loan Documents, dated as of July 11, 2012, among the Company, Emergent Manufacturing Operations Baltimore LLC, Emergent BioDefense Operations Lansing LLC and PNC Equipment Finance, LLC.
2012-08-0310-Q10.7First Amendment to Loan Documents, dated as of June 26, 2012, among the Company, Emergent Manufacturing Operations Baltimore LLC, Emergent BioDefense Operations Lansing LLC and PNC Bank, National Association.
2012-08-0310-Q10.6Amendment to Lease Agreement, dated July 26, 2012, between Emergent Product Development Seattle, LLC and Selig Real Estate Holdings Eight, LLC.
2012-08-0310-Q10.3Modification No. 16 to Contract No. HHS0100200700037C, dated June 1, 2012, between Emergent BioDefense Operations Lansing LLC and the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services.
2012-08-0310-Q10.2Modification No. 11 to Contract No. HHSO100201000034C, dated July 18, 2012, between Emergent Biodefense Operations Lansing LLC and the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services.
2012-08-0310-Q10.1Modification No. 8 to Contract No. HHSO100201000034C, dated December 6, 2011, between Emergent Biodefense Operations Lansing LLC and the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services.
2012-05-0410-Q10.6Amendment to Consulting Agreement, dated effective January 1, 2012, between Emergent BioSolutions Inc. and Robert Kramer
2012-05-0410-Q10.5Consulting Agreement, dated effective September 6, 2011, between Emergent BioSolutions Inc. and Robert Kramer
2012-05-0410-Q10.4Solicitation, Offer and Award, dated effective September 30, 2011, from the Centers for Disease Control and Prevention to Emergent BioDefense Operations Lansing LLC
2012-03-0910-K10.47Third Amendment to Lease Agreement, dated effective February 27, 2012, between Brandywine Research LLC and the Registrant
2012-03-0910-K10.46Second Amendment to Lease Agreement, dated December 13, 2010, between Brandywine Research LLC and the Registrant
2012-03-0910-K10.45First Amendment to Lease Agreement, dated November 13, 2007, between Brandywine Research LLC and the Registrant
2012-03-0910-K10.18Modification No. 14 to Contract No. HHS0100200700037C, effective January 3, 2012, between Emergent BioDefense Operations Lansing LLC, formerly known as Emergent BioDefense Operations Lansing Inc., and the Department of Health and Human Services
2012-03-0910-K10.17Modification No. 13 to Contract No. HHS0100200700037C, dated October 21, 2011, between Emergent BioDefense Operations Lansing LLC, formerly known as Emergent BioDefense Operations Lansing Inc., and the Department of Health and Human Services
2012-03-0910-K10.11TERMS AND CONDITIONS OF EMPLOYMENT CONTRACT

Similar stocks

Stock NameCountryMarket CapPE Ratio
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Rezolute, Inc. (RZLT)United States$0.382B-6.45